July 14, 2014 11:53 am
POST SUMMARY: The trouble with people who think they are smarter than everyone else is that they can’t learn from others because they think they know it all. more>>
Those who access health content are also doing so using more than just PCs. In April 2013, 35 percent of visitors used mobile devices to consume health information. A year later, almost half of health information-seekers used mobile devices to consume health content. This uptick in mobile usage suggests two things: an increased reliance in managing one’s health issues on-the-go, and an increase in tablet usage at home instead of the PC. For those using mobile devices out-of-home to manage health issues, uses included understanding symptoms, treating a condition, or achieving one’s health goals. Comscore’s research indicates more specifically that on-the-go mobile users seek health information at doctor’s offices and while waiting for prescription refills at the pharmacy.
POST SUMMARY: WebMD Health Corp. said it is suing Everyday Health Inc for trademark infringement, false advertising and unfair competition. This is very much the battle for ad dollars as well as stock price and the outcome should be interesting.
POST SUMMARY: Big pharma companies continue to be defined by a myriad of external sources from Congress, questioning high drug prices, to seemingly unorthodox behavior like putting profits over patient safety as in the Boehringer Ingelheim Pradaxa case. However, biotech companies like Biogen continue to develop and market new drugs by tossing out the big pharma business models and focusing on patients.
The IMS Institute of Health Informatics released a report today called “riding the technology wave in life sciences” and there are some troubling findings. Among one of their key findings “despite abundant and growing amounts of data being generated and accessed by life sciences companies, analytic systems designed to interpret and create actionable insights have not kept pace.”
Once again the NY Times has taken the pharma industry to task with a front page story on the ADHD market. In fact the subtitle of the story “The Number of Diagnoses Soared Amid a 20-Year Drug Marketing Campaign”[pretty much sums up the article’s thesis. While it’s true that the drug industry has made some mistakes in marketing ADHD products let’s not forget that parents want an “easy fix” to get their kids better grades and patients still have to go through their physician to get an Rx.
Amanda Marcotte, via Slate said “Marshall was only given a few minutes to state that vaccines are safe and that the side effects mentioned by other guests were probably unrelated to the vaccine. Unfortunately, Couric and her producers allowed these facts to be totally overshadowed by the heartrending tales told by the two mothers. Despite H assurances that regular Pap smears are no big deal, the truth is that some women can’t or won’t go to the doctor as often as they should, especially in their 20s. Which is why the vaccine is so important: It’s easy, extra protection that will save some of their lives.” This is what happens when “journalists” lose their reporting skill and play to audience fears.
According to Business Intelligence “The TV business has had its worst year ever. Audience ratings have collapsed: Aside from a brief respite during the Olympics, there has been only negative ratings growth on broadcast and cable TV since September 2011, according to Citi Research.” While the national network news seems to be sponsored by pharma companies consumers are consuming media elsewhere and time shifting their favorite shows because repetitive tv commercials are downright annoying.
According to the NY Times “a decision announced Thursday by the Food and Drug Administration to suspend sales of a leukemia drug, Iclusig, that was keeping patients alive but also significantly raising their odds of heart attacks, strokes, blindness, death and amputations” has led to concern that patients who are using the drug to stay alive may soon find it hard to refill their prescriptions. “Despite the potential consequences, several doctors who treat people with the disease, chronic myeloid leukemia, said there were patients for whom nothing else works, and whose lives depend on the drug.” So who really should make the decision about treatment options ?